BPIQ Blog

$XBI $91.38 | -0.80% Covid Updates $VALN +6.5% Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine...

$XBI $92.11 | +2.31% Covid Updates $SRNE -7.1% Sorrento Receives Purchase Order for 10 Million Covistix Tests From Its Subsidiary...

$XBI $90.03 | -2.1% Covid Updates $GILD +1.0% FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High...

$XBI $91.70 | -1.64% Covid Updates $ Pipeline Updates $PRVB -1.8% Provention Bio Announces Initiation of the Phase 2a PREVAIL-2 Study...

$XBI $93.50 | -1.08% Covid Updates $NVAX -6.2% Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for...

$XBI $94.52 | -5.94% Covid Updates $SRNE -7.2% Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial...

$XBI $100.49 | +2.44% d Covid Updates $RDHL +2.9% RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase...

$XBI $98.10 -2.5% Covid Updates $RDHL -1.6% RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study...

$XBI $100.60 -3.2% Covid Updates $OCGN +0.24 COVAXIN™ (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2...

$XBI $103.89 0.73% % Covid Updates $TNXP +1.7% Tonix Pharmaceuticals Initiates Enrollment in Clinical Trial of TNX-2100, a Diagnostic...

$XBI $103.14 +0.2% % Covid Updates $NVAX +6.5% Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax'...

$XBI $102.99 | -2.1% % Pipeline Updates $IOVA +1.4% Iovance Biotherapeutics to Present Data on Tumor-Infiltrating Lymphocyte (TIL) Cell...

$XBI $105.20 -0.03% % Covid Updates $COCP -3.1% Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19...

$XBI $105.23 -5.50% % Covid Updates $NRXP +3.0% NRx Pharmaceuticals Submits Emergency Use Authorization Application to US Food and Drug...

$XBI $111.36 -3.53% % Covid Updates $GRTS -42.4% Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study...

$XBI $115.44 +3.11% % Covid Updates $MRNA -7.5% Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of...

$XBI $111.96 | -1.13%% Covid Updates $VIR Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron...

$XBI $113.24 +0.44%% Covid Updates $OCGN +10.3% Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From...

$XBI $113.21 -1.7%% Covid Updates $DVAX -1.3% COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant Receives India...

$XBI $115.17 -2.6%% Covid Updates $MRNA -1.2% Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional...